REFERENCES
- Whitcup SM. Intermediate uveitis. In: Nussenblatt RB, Whitcup SM, eds. Uveitis: Fundamentals and Clinical Practice. Philadelphia, PA: Mosby Elsevier; 2010: 269–277.
- Jamal KN. Callanan DG. The role of difluprednate ophthalmic emulsion in clinical practice. Clin Ophthalmol. 2009; 3: 381–390.
- Kornfeld MS, Silverstein, SM, Cooke, DL, Vogel, R, Crockett, RS. Difluprednate ophthalmic emulsion 0.05% for postoperative inflammation and pain. J Cat Refract Surg. 2009; 35:26–34.
- Tajika T, Shirasaki Y, Kimura M, et al. Ocular distribution and metabolism after instillation of difluprednate ophthalmic emulsion in rabbits. The 2007 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO). Poster B744, Program 2654, Fort Lauderdale, FL, USA, 6–10 May 2007.
- Nakano S, Yamamoto T, Kirii, E, Abe S, Yamashita H. Steroid eye drop treatment (difluprednate ophthalmic emulsion) is effective in reducing refractory diabetic macular edema. Graefes Arch Clin Exp Ophthalmol. 2010; 248:805–810.
- Plitz-Seymour, J. Uhler, TA. Other secondary glaucomas. In: Shaarawy, TM, Sherwood, MB, Hitchings, RA, Crowston, JG, eds. Glaucoma: Medical Diagnosis and Therapy, Vol. 1. Printed in China: Saunders Elsevier; 2009: 419–430.